Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aurobindo Pharma Ltd ( (IN:AUROPHARMA) ) has provided an update.
Aurobindo Pharma Limited has notified stock exchanges that its officials will participate in an analyst and investor group plant visit on March 16, 2026. The in-person visit, scheduled from 9:00 a.m. to 5:00 p.m. IST, will take place at the company’s manufacturing sites in Vizag and Kakinada.
The company emphasized that no unpublished price-sensitive information will be shared during these interactions, in line with regulatory norms. This outreach underscores Aurobindo Pharma’s ongoing efforts to engage with the investment community and provide greater operational visibility without compromising disclosure standards.
More about Aurobindo Pharma Ltd
Aurobindo Pharma Limited is an India-based pharmaceutical company operating in the generic drugs and formulations industry. It manufactures and supplies a broad range of medicines and active pharmaceutical ingredients, with a significant presence in both domestic and international markets, supported by multiple production facilities across locations such as Vizag and Kakinada.
Average Trading Volume: 74,567
Technical Sentiment Signal: Strong Buy
Current Market Cap: 746.8B INR
For detailed information about AUROPHARMA stock, go to TipRanks’ Stock Analysis page.